Investor Relations

Organigram is a leading Canadian licensed producer of high-quality medical and recreational cannabis.

NASDAQ (OGI) TSX (OGI)

Investor’s Presentation

View Presentation

Our Facility

Press Releases

October 30th, 2020

Organigram CEO Joins Canadian Chamber of Commerce Board of Directors

October 23rd, 2020

Organigram Confirms Additional $2.5 Million Investment in Hyasynth Biologicals Inc. as Biosynthesis Pioneer Completes First Milestone Linked to First Sale of Commercial Product and Announces Executive Changes

September 17th, 2020

Organigram Expands Strong Value Portfolio With Launch of SHRED: High Quality, High Potency, Affordable Pre-shredded Dried Flower

All Press Releases

Investor Events

September 17th, 2020

CIBC Eastern Institutional Investor Conference

August 13th, 2020

Canaccord Growth Conference

Call Replay Presentation

July 21st, 2020

Q3 2020 - Earnings Release and Webcast

Call Replay Press Release Presentation Transcript